Skip to main content
. Author manuscript; available in PMC: 2020 Jul 7.
Published in final edited form as: Prostate. 2011 Feb 9;71(13):1382–1389. doi: 10.1002/pros.21354

Table I.

Information about 14 genotyped SNPs in five arachidonic acid metabolism pathway genes

Genes SNP ID SNP region Base
change
P, HWEa Basis of selection
Details Referenceb Epidemiologic Associations Reference
Prostaglandin Synthesis Subpathway
PTGS2/ COX2 rs2745557 Intronic G>A 0.40 (15) Prostate cancer (16)
PTGES2 rs884115 Intronic C>T 0.72 Haplotype tagging SNP (36)
rs10987883 Intronic A>G 0.85 Haplotype tagging SNP (36)
rs13283456 Intronic C>T 0.25 Missense; Arg298His Body mass index; Type 2 diabetes (36,37)
rs4837240 3’ UTR G>A 0.18 Haplotype tagging SNP (36)
Leukotriene Synthesis Subpathway
ALOX5 rs2029253 Intronic A>G <.001 Acute coronary syndrome (38)
rs12762303 Promoter T>C 0.41 Coronary artery disease (39)
rs2228065 Exon 6 G>T 1.0 Missense; Glu254Lys (40) Tuberculosis (41)
rs6593482 VNTR G>T <.001
ALOX5AP rs12721458 Intronic C>G 0.84
rs4076128 5’UTR A>G <.001 Breast cancer (10)
rs4073259 5’UTR G>A 0.13 Myocardial infarction (42)
LTA4H rs2660845 5’UTR A>G 0.17 Asthma (43)
rs1978331 Intronic T>C 0.65 Higher level of LB4c associated with T allele (33,42) Asthma; leprosy; tuberculosis (30,33)
a

P-values from Chi-squared test for Hardy-Weinberg equilibrium in controls. SNPs with significant p-values were excluded from further analysis.

b

Information from HapMap where not otherwise indicated.

c

LB4= leukotriene B4

HHS Vulnerability Disclosure